Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease

Schapiro, M B; Pietrini, P; Grady, C L; Ball, M J; DeCarli, C; Kumar, A; Kaye, J A; Haxby, J V
August 1993
Journal of Neurology, Neurosurgery & Psychiatry;Aug1993, Vol. 56 Issue 8, p859
Academic Journal
journal article
No abstract available.


Related Articles

  • Voxel-based analysis of cerebral glucose metabolism in mono- and dizygotic twins discordant for Alzheimer disease. J J Virta // Journal of Neurology, Neurosurgery & Psychiatry;Mar2009, Vol. 80 Issue 3, p259 

    BACKGROUND: Sporadic Alzheimer disease (AD) is a multifactorial disease to which both genetic and environmental factors contribute. Therefore, twin pairs are useful in studying its pathogenesis and aetiology. Cerebral glucose metabolism has been found to be reduced in AD patients. METHODS:...

  • Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimers disease. Gwenn S. Smith; Elisse Kramer; Yilong Ma; Carol R. Hermann; Vijay Dhawan; Thomas Chaly; David Eidelberg // Brain: A Journal of Neurology;Feb2009, Vol. 132 Issue 2, p392 

    Pre-clinical and human neuropharmacological evidence suggests a role of cholinergic modulation of monoamines as a pathophysiological and therapeutic mechanism in Alzheimers disease. The present study measured the effects of treatment with the cholinesterase inhibitor and nicotinic receptor...

  • Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance. Castellano, Christian-Alexandre; Baillargeon, Jean-Patrice; Nugent, Scott; Tremblay, Sébastien; Fortier, Mélanie; Imbeault, Hélène; Duval, Julie; Cunnane, Stephen C. // PLoS ONE;12/9/2015, Vol. 10 Issue 12, p1 

    Objective: To investigate whether cerebral metabolic rate of glucose (CMRglu) is altered in normal weight young women with polycystic ovary syndrome (PCOS) who exhibit mild insulin resistance. Materials and methods: Seven women with PCOS were compared to eleven healthy female controls of...

  • An Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimerµs Disease. Shah, Raj C.; Matthews, Dawn C.; Andrews, Randolph D.; Capuano, Ana W.; Fleischman, Debra A.; VanderLugt, James T.; Colca, Jerry R. // Current Alzheimer Research;Jul2014, Vol. 11 Issue 6, p564 

    Alzheimer's disease (AD) is associated with insulin resistance and specific regional declines in cerebral metabolism. The effects of a novel mTOT modulating insulin sensitizer (MSDC-0160) were explored in non-diabetic patients with mild AD to determine whether treatment would impact glucose...

  • Hypometabolism as a therapeutic target in Alzheimer's disease. Costantini, Lauren C.; Barr, Linda J.; Vogel, Janet L.; Henderson, Samuel T. // BMC Neuroscience;2008 Supplement 2, Vol. 9, Special section p1 

    The pathology of Alzheimer's disease (AD) is characterized by cerebral atrophy in frontal, temporal, and parietal regions, with senile plaques, dystrophic neurites, and neurofibrillar tangles within defined areas of the brain. Another characteristic of AD is regional hypometabolism in the brain....

  • A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration. Poljansky, Stefan; Ibach, Bernd; Hirschberger, Barbara; M�nner, Peter; Kl�nemann, Hans; Hajak, G�ran; Marienhagen, J�rg // European Archives of Psychiatry & Clinical Neuroscience;Sep2011, Vol. 261 Issue 6, p433 

    This study presents a visual rating scale for the assessment of cerebral [F]fluoro-2-deoxy- d-glucose positron emission tomography (FDG-PET) scans to characterize typical findings in dementias associated with frontotemporal lobar degeneration (FTLD) and to differentiate individual patients with...

  • Neural Correlates of Cognition Deficits in Mild Cognitive Impairment and Alzheimer's Disease. Schönknecht, Oskar Dieter Peter; Toro, Pablo; Hunt, Aoife; Henze, Marcus; Haberkorn, Uwe; Schröder, Johannes // Mind & Brain, The Journal of Psychiatry;Jul2011, Vol. 2 Issue 1, p1 

    INTRODUCTION Alzheimer's disease (AD) and mild cognitive impairment (MCI) as its preclinical syndrome are characterized by a variety of cognitive deficits that can be assessed by using the neuropsychological test battery of the CERAD. The cerebral changes underlying the respective cognitive...

  • Quintessential Risk Factors: Their Role in Promoting Cognitive Dysfunction and Alzheimer's Disease. Daulatzai, Mak // Neurochemical Research;Dec2012, Vol. 37 Issue 12, p2627 

    Alzheimer's disease (AD) is a progressive neurodegenerative disorder. The human brain is extremely sensitive to hypoxia, ischemia, and glucose depletion. Impaired delivery of oxygen in obstructive sleep apnea (OSA) alters neuronal homeostasis, induces pathology, and triggers neuronal...

  • Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). Henkel, Karsten; Zerr, Inga; Hertel, Andreas; Gratz, Klaus-F.; Schröter, Andreas; Tschampa, Henriette J.; Bihl, Heiner; Büll, Udalrich; Grünwald, Frank; Drzezga, Alexander; Spitz, Jürg; Poser, Sigrid // Journal of Neurology;Jun2002, Vol. 249 Issue 6, p699 

    The aim of this study was to explore the sites of metabolic changes with [18F]2-fluoro-2-desoxy-D-glucose (FDG) and positron emission tomography (PET) in patients with Creutzfeldt-Jakob disease and to correlate the findings with clinical symptoms. Static [18F]FDG-PET studies of eight patients...

  • Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. Garcia-Garcia, David; Clavero, Pedro; Gasca Salas, Carmen; Lamet, Isabel; Arbizu, Javier; Gonzalez-Redondo, Rafael; Obeso, Jose; Rodriguez-Oroz, Maria // European Journal of Nuclear Medicine & Molecular Imaging;Nov2012, Vol. 39 Issue 11, p1767 

    Purpose: Patients with Parkinson's disease (PD) may have normal cognition, mild cognitive impairment (MCI) or dementia. We investigated differences in cerebral metabolism associated with these three cognitive states and the relationship between metabolism and cognitive dysfunction. Methods: FDG...


Read the Article


Sign out of this library

Other Topics